Effects of Angelica keiskei Koidzumi and Turmeric Extract Supplementation on Serum Lipid Parameters in Hypercholesterolemic Diet or P-407-Induced Hyperlipidemic Rats |
Kim, Tae-Hyun
(D&P Natural Product Research Cooperation)
Son, Yeon-Kyung (D&P Natural Product Research Cooperation) Hwang, Keum-Hee (Bio-Food and Drug Research Center, Konkuk University) Kim, Mi-Hyun (Dept. of Food and Nutrition, Kangwon National University) |
1 | Ogawa H, Ohno M, Baba K. 2005. Hypotensive and lipid regulatory actions of 4-hydroxyderricin, a chalcone from Angelica keiskei, in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 32: 19-23 DOI ScienceOn |
2 | Wasan KM, Subramanian R, Kwong M, Goldberg IJ, Wright T, Johnston TP. 2003. Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats. J Pharm Pharm Sci 6: 189-197 |
3 | Ogawa H, Nakashima S, Baba K. 2003. Effects of dietary Angelica keiskei on lipid metabolism in stroke-pronespontaneously hypertensive rats. Clin Exp Pharmacol Physiol 30: 284-288 DOI |
4 | Soni KB, Kuttan R. 1992. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 36: 273-275 |
5 | Ogawa H, Nakamura R, Baba K. 2005. Beneficial effect of laserpitin, a coumarin compound from Angelica keiskei, onlipid metabolism in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 32: 1104-1109 DOI ScienceOn |
6 | Ramirez-Tortosa MC, Mesa MD, Aguilera MC, Quiles JL, Baro L, Ramirez-Tortosa CL, Martinez-Victoria E, Gil A. 1999. Oral administration of turmeric extract inhibit LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 147: 371-378 DOI ScienceOn |
7 | Arafa HM. 2005. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 11: BR228-234 |
8 | Johnston TP, Nguyen LB, Chu WA, Shefer S. 2001. Potency of select statin drugs in a new mouse model of hyperlipidemia andatherosclerosis. Int J Pharm 229: 75-86 DOI ScienceOn |
9 | Blonder JM, Baird L, Fulfs JC, Rosenthal GJ. 1999. Dosedependent hyperlipidemia in rabbits following administration of poloxamer 407 gel. Life Sci 65: PL261-266 DOI ScienceOn |
10 | Park JC, Cho YS, Park SK, Park JR, Chun SS, Ok KD, Choi JW. 1995. Isolation of flavone-7-O-glycosides from the aerial parts of Angelica keiskei and anti-hyperlipidemic effect. Koran J Pharmacogn 26: 337-343 과학기술학회마을 |
11 | Rao DS, Sekhara NC, Satyanarayana MN, Srinivasan M. 1970. Effect of curcumin on serum and liver cholesterol levels in the rat. J Nutr 100: 1307-1315 |
12 | Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Piromohamed M, Marnett LJ, Gescher AJ, Steward WP. 2001. Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clin Cancer Res 7: 1894-1900 |
13 | Song EK, Cho H, Kim JS, Kim NY, An NH, Kim JA, Lee SH, Kim YC. 2001. Diary heptanoids with free radical scavenging and hepatoprotective activity in vitro from Curcuma longa. Plant Med 67: 876-877 DOI ScienceOn |
14 | Wout ZG, Pec EA, Maggiore JA, Williams RH, Palicharla P, Johnston TP. 1992. Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats. J Parenter Sci Technol 46: 192-200 |
15 | Son IS, Kim JH, Sohn HY, Son KH, Kim JS, Kwon CS. 2007. Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats. Biosci Biotechnol Biochem 71: 3063-3071 DOI ScienceOn |
16 | Ogawa H, Okada Y, Kamisako T, Baba K. 2007. Beneficial effect of xanthoangelol, a chalcone compound from Angelica keiskei, onlipid metabolism in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 34: 238-243 DOI ScienceOn |
17 | Miettinen TA. 2001. Cholesterol absorption inhibition: a strategy for cholesterol-lowering therapy. Int J Clin Prat 55: 710-716 |
18 | National Statistical Office. 2006 Death by Causes. 2007 |
19 | Frohlich J, Lear SA. 2002. Old and new risk factors for atherosclerosis and development of treatment recommendations. Clin Exp Pharmacol Physiol 29: 838-842 DOI ScienceOn |
20 | Mckenny JM. 2001. Lipid management: tools for getting to the goal. Am J Manag Care 7: S299-S306 |
21 | Palmer WK, Emeson EE, Johnston TP. 1998. Poloxamer 407-induced atherogenesis in the C57BL/6 mouse. Atherosclerosis 136: 115-123 DOI ScienceOn |
22 | Park JR, Park JC, Choi SH. 1997. Screening and characterization of anticholesterolgenic substances from edible plant extracts. J Korean Soc Food Sci Nutr 26: 236-241 과학기술학회마을 |
23 | Johnston TP, Palmer WK. 1993. Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat. Biochem Pharmacol 46: 1037-1042 DOI ScienceOn |